Mutations in mitochondrial DNA (mtDNA) can cause mitochondrial disease, a group of metabolic disorders that affect both children and adults. Interestingly, individual mtDNA mutations can cause very different clinical symptoms, however the factors that determine these phenotypes remain obscure. Defects in mitochondrial oxidative phosphorylation can disrupt cell signaling pathways, which may shape these disease phenotypes. In particular, mitochondria participate closely in cellular calcium signaling, with profound impact on cell function. Here, we examined the effects of a homoplasmic m.13565C>T mutation in MT-ND5 on cellular calcium handling using transmitochondrial cybrids (ND5 mutant cybrids). We found that the oxidation of NADH and mitochondrial membrane potential (Δψ m ) were significantly reduced in ND5 mutant cybrids. These metabolic defects were associated with a significant decrease in calcium uptake by ND5 mutant mitochondria in response to a calcium transient. Inhibition of glycolysis with 2-deoxy-D-glucose did not affect cytosolic calcium levels in control cybrids, but caused an increase in cytosolic calcium in ND5 mutant cybrids. This suggests that glycolytically-generated ATP is required not only to maintain Δψ m in ND5 mutant mitochondria but is also critical for regulating cellular calcium homeostasis. We conclude that the m.13565C>T mutation in MT-ND5 causes defects in both mitochondrial oxidative metabolism and mitochondrial calcium sequestration. This disruption of mitochondrial calcium handling, which leads to defects in cellular calcium homeostasis, may be an important contributor to mitochondrial disease pathogenesis.
Introduction
Mitochondria provide the main source of energy in eukaryotic cells, oxidizing sugars, fats and amino acids to generate ATP by oxidative phosphorylation (OXPHOS). This series of enzymatic reactions is performed by five protein complexes (I-V) within the mitochondrial inner membrane. Complex I (NADH: ubiquinone oxidoreductase) and II (succinate-ubiquinone oxidoreductase) accept electrons from the TCA cycle, which are then passed to molecular oxygen via complexes III (ubiquinol: cytochrome c oxidoreductase) and IV (ferrocytochrome c: oxygen oxidoreductase). This transfer of electrons induces the pumping of protons out of the mitochondrial matrix by complexes I, III and IV to generate a mitochondrial membrane potential (Δψ m ), which is subsequently used by complex V (F o F 1 -ATP synthetase) to generate ATP [1] .
Mitochondria are unique organelles in that they contain their own circular genome. Mitochondrial DNA (mtDNA) encodes 13 polypeptides, all of which are protein subunits of the OXPHOS complexes I, III, IV and V. The mitochondrial genome also encodes the 12S and 16S rRNAs, as well as the 22 tRNAs that are specific for mitochondrial protein synthesis.
Mutations in mtDNA can disrupt OXPHOS function and cause mitochondrial disease, a diverse group of multi-systemic disorders that commonly affect the brain, heart and skeletal muscle. This includes syndromes such as mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS), a heterogeneous disorder that presents with myopathy, encephalopathy and features of central nervous system involvement [2] . Conversely, some mtDNA mutations result in isolated symptoms, such as Leber Hereditary Optic Neuropathy (LHON), a form of acute blindness due to the specific loss of retinal ganglion cells in the optic nerve [3] .
Apart from their essential role in generating ATP, mitochondria also perform many other important functions. In particular, mitochondria act as local calcium (Ca 2+ ) buffers to tightly regulate intracellular Ca 2+ concentration [4] . Mitochondrial utilize their Δψ m to sequester
, allowing them to shape spatiotemporal cytosolic Ca 2+ signaling within the cell [5] . The influx of Ca 2+ into the mitochondria subsequently promotes the activity of three rate-limiting dehydrogenases of the citric acid cycle, which in turn upregulates OXPHOS [6] . In this way, mitochondrial calcium handling and OXPHOS function are tightly interlinked. Apart from disrupting mitochondrial ATP production, mtDNA mutations have also been shown to cause mitochondrial Ca 2+ handling defects. In fibroblasts from patients with MELAS, levels of ionized Ca 2+ at rest are elevated compared to controls, with both Δψ m and mitochondrial Ca 2+ sequestration diminished [7] . Similarly, calcium homeostasis is altered in cybrids generated from the fibroblasts of patients with myoclonic epilepsy with ragged-red fibers (MERRF) [8] .
We have previously shown that transmitochondrial cybrid cells carrying a homoplasmic m.13565C>T mtDNA mutation, which results in a p.Ser410Phe amino acid change in the complex I subunit ND5, have defects in mitochondrial respiration and a reduced Δψ m [9] . Here, we examined the effects of this mutation on cell Ca 2+ homeostasis and mitochondrial calcium handling, and found that mutant cybrid mitochondria have reduced levels of stored Ca 2+ and a decreased capacity to accumulate increases in cytoplasmic Ca
2+
. These findings aid our understanding of the connection between OXPHOS dysfunction and mitochondrial Ca 2+ homeostasis and how both can contribute to mitochondrial disease pathogenesis.
Materials and Methods

Cell lines and chemicals
All chemicals were from Sigma (St, Louis, MO, USA) unless otherwise specified. All cells were grown in RPMI 1640 Medium (ThermoFisher Scientific, Waltham, MA, USA) supplemented with 10% fetal bovine serum (ThermoFisher), 4.5 mg/mL glucose, 50 μg/mL uridine, and 1 mM pyruvate at 37°C and 5% CO 2 unless otherwise specified.
Human mitochondrial cybrids used in this study were generated as previously described using mtDNA-less 143B osteosarcoma cells (ρ 0 ) as the nuclear donors [9] . Cybrids contained either control wild-type mtDNA (CON) or a homoplasmic m.13565C>T mutation in the MT-ND5 gene (ND5) which was captured from fibroblasts from a patient with mitochondrial encephalomyopathy and lactic acidosis with stroke-like episodes (MELAS) [9] .
Fluorescent Imaging of Cell Calcium
For measurements in the presence of calcium, cells were incubated in buffer containing 156 mM NaCl, 3 mM KCl, 2 mM MgSO 4 , 1.25 mM KH 2 PO 4 , 10 mM D-glucose, 2 mM CaCl 2 , 10 mM HEPES pH 7.35 (Record Solution, RS), 5 μg/mL fura-2 AM (ThermoFisher) and 0.005% pluronic (ThermoFisher) for 30 min in RS. Cells were then washed with 1xPBS before imaging in RS, with 10 μM ionomycin or 5 mM 2-deoxy-D-glucose (2DG) added as indicated.
For measurements in the absence of calcium, cells were incubated in buffer containing 156 mM NaCl, 3 mM KCl, 2 mM MgSO 4 , 1.25 mM KH 2 PO 4 , 10 mM D-glucose, 10 mM HEPES pH 7.35, 0.1 mM EGTA (Ca 2+ free RS), 5 μg/mL fura-2 AM and 0.005% pluronic for 30 min.
Cells were then washed with 1xPBS before imaging in Ca 2+ free RS, with additions of 1 μM thapsigargin and 10 μM ionomycin added as indicated. Fluorescent images were captured on a Nikon epifluorescence inverted microscope with a 40X objective. A xenon arc lamp with 10 nm band-pass filters centered at 340 and 380 nm was used for excitation (Cairn Research, Kent, UK), with emitted light passing through a 515 nm long-pass filter to an interline transfer cooled CCD camera (Orca ER, Hamamatsu). Images were digitized to 12-bit and analyzed using Kinetic Imaging software (Liverpool, UK).
Fluorescent Imaging of Mitochondrial Calcium and Mitochondrial Membrane Potential
Mitochondrial membrane potential (Δψ m ) was measured by incubating cells in RS with 20 nM tetramethylrhodamine, methyl ester, perchlorate (TMRM) (ThermoFisher) and 10 μM verapamil (which is required to inhibit TMRM export from the cell on the multidrug transporter). Cells were allowed to equilibrate the dye for at least 45 min at room temperature before imaging. [10] . Δψ m and fluo-4 calcium measurements were made by acquiring images with a Carl Zeiss 510 inverted laser scanning confocal microscope (Oberkochen, Germany). TMRM and fluo-4 were excited using 543 nm He-Ne and 488 nm argon laser lines, respectively. NADH autofluorescence was measured using the 362 nm UV laser line. Images were analyzed using Carl Zeiss or Kinetic Imaging software, with mitochondrial calcium measured by selecting regions of interest that specifically co-localized with mitochondrial TMRM signals.
Statistical analyses for all experiments were performed using imaging data from three separate experiments, with significant differences determined using Student's two-tailed t-tests.
Results
NADH oxidation by Complex I is reduced in ND5 mutant cybrids
We first examined the impact of the m.13565C>T mutation on mitochondrial function. Measurements of NADH 'auto' fluorescence reflects the redox balance of the NAD+/NADH pool, as only NADH is fluorescent. We explored the relationship between mitochondrial NADH redox state and Δψ m by inhibiting cytochrome c oxidase (Complex IV) with cyanide (CN -), which blocks electron flow through the respiratory chain. In the control cybrid (CON), CN -treatment caused the inhibition of NADH oxidation by Complex I, as observed by an increase in NADH autofluorescence ( Fig 1A) . However, blocking electron flow with CN -did not collapse Δψ m , as the F o F 1 -ATP synthetase switches to function in reverse, maintaining Δψ m [11] (Fig 1B) .
Blockade of Complex IV with CN -in the ND5 mutant cybrid did not alter NADH oxidation, suggesting that at rest the rate of NADH oxidation by complex I is very low (Fig 1A) . Δψ m in ND5 mutant cybrids, which is lower than in control cybrids, was also unchanged upon the addition of CN -, as it is maintained by reverse function of the F o F 1 -ATPase as previously shown [9] (Fig 1B) . As ρ 0 cells do not have functional OXPHOS complexes to generate a Δψ m , they maintain a potential through the reversal of both the ANT and an incomplete F o F 1 -ATPase [9, 12] . Thus, the addition of CN -had no effect either on NADH oxidation or Δψ m in ρ 0 cells (Fig 1A and 1B) .
The protonophore carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) will always collapse any potential based on proton distribution. In the control cybrid (CON), FCCP caused a collapse of Δψ m and the rapid oxidation of NADH (indicated by a decrease in NADH autofluorescence) as respiration is stimulated (Fig 1B) . NADH oxidation increased modestly in ND5 mutant cybrids after depolarization with FCCP, suggesting that there is a small reserve respiratory capacity when stimulated (Fig 1A) . This result concurs with our previous findings, where the ratio of uncoupled/coupled respiration (as an indicatory of reserve respiratory capacity) was only 1.25 in ND5 mutant cybrid cells (compared to a ratio of 2.0 in control cybrid cells (p<0.05)) [9] . FCCP did not stimulate NADH oxidation in ρ 0 cells (Fig 1A) , despite collapsing the small Δψ m (Fig 1B) , confirming the absence of functional OXPHOS in these cells.
Levels of stored calcium are reduced in ND5 mutant cybrids
We used the ratiometric dye fura-2 to perform a quantitative comparison of cytosolic free Ca ] c was significantly higher in ρ 0 cells (p<0.05) (Fig 2A) . This is most likely a result of impaired Ca 2+ clearance mechanisms due to the ATP depletion observed in this cell type [12, 13] . The Ca 2+ ionophore ionomycin, at a concentration of 10 μM, releases Ca 2+ preferentially from the endoplasmic reticulum (ER) and the mitochondria into the cytosol. Ionomycin treatment revealed significantly less stored Ca 2+ in ND5 mutant cybrids (45.3 ± 11.0% of control (CON) cybrids, p<0.05) (Fig 2A) . Stored Ca 2+ in ρ 0 cells was also significantly less than in control cybrids (22.4 ± 6.2%, p<0.05) (Fig 2A) . We also examined the release of stored Ca 2+ in the absence of extracellular Ca 2+ (Ca 2+ free RS) (Fig 2B) . Under these conditions, there was no significant difference in the levels of resting [Ca 2+ ] c in control (CON) cybrids, ND5 mutant cybrids or ρ 0 cells (Fig 2B) . However, the addition of ionomycin resulted in a similar pattern of Ca 2+ release, in that the increase in [Ca 2+ ] c was significantly reduced in ND5 cybrids (36.6 ± 4.6%, p<0.05) and ρ 0 cells (17.9 ± 3.7%, p<0.05) compared to the controls (Fig 2B) . The total increase in [Ca 2+ ] c induced by ionomycin was reduced in each cell type compared to our findings presented in Fig 2A, as would be expected in the absence of free extracellular Ca 2+ (Fig 2B) .
We next used thapsigargin to measure the release of Ca 2+ specifically from the ER, followed by ionomycin, which will then release calcium sequestered in the mitochondria. ] c . Subsequent addition of ionomycin, in the absence of extracellular free Ca 2+ , will then release Ca 2+ from any remaining intracellular pool, which will be dominated by the mitochondria. Cells were incubated in Ca 2+ free buffer, followed by the addition of thapsigargin. This resulted in the release of Ca 2+ from ER stores in both control (CON) cybrids and ND5 mutant cybrids (Fig 3) . Although this Ca 2+ release was both reduced and delayed in ND5 mutant cybrids, neither was statistically significant. In comparison, ρ 0 cells showed no significant release of ER Ca
2+
, suggesting that the ATP depletion observed in these cells disrupts ER Ca 2+ uptake [12, 13] (Fig 3) . Subsequent addition of ionomycin released Ca 2+ from the mitochondria in both control (CON) and ND5 mutant cybrids, however, stored Ca 2+ in ND5 mutant mitochondria was significantly lower (66.4 ± 15.8%, p<0.05) (Fig 3) . Releasable Ca 2+ in ρ 0 cell mitochondria was also significantly lower than the control cybrid (21.3 ± 11.7%, p<0.05) (Fig 3) .
Mitochondrial calcium buffering power is significantly reduced in ND5 mutant cybrids
In order to measure the ability of the mitochondria to buffer increases in Ca 2+ , cybrids were loaded with fluo-4 and then permeabilized with digitonin in a cytosol-like buffer (intracellular medium, IM) containing 62 nM free Ca
2+
. In addition, thapsigargin was added to deplete ER Ca 2+ stores. Under these conditions, fluo-4 is lost from both the cytosol and ER, with the only dye remaining trapped in the mitochondria (Fig 4C) ] m in control cybrids (Fig 4A) , although slight depolarization and recovery of Δψ m is evident (Fig 4B) . Further increases to ] c was measured using the ratiometric dye fura-2 AM on an epifluorescence imaging system. Increases in [Ca 2+ ] c were significantly lower in ND5 mutant cybrids and ρ 0 cells than in control (CON) cybrids after the addition of the calcium ionophore ionomycin in either calcium-containing (A) or a calcium-free buffer (B). Data is mean ± s.d. n = 3. *p<0.05. ], an intact Δψ m was still evident, as the addition of 10 μM FCCP still induced the collapse of Δψ m (Fig 4B) .
In contrast, mitochondrial calcium accumulation was reduced significantly in ND5 mutant cybrids, and no increase in [ ] m only 59.1% of control cybrid mitochondria (Fig 4A) .
We have previously observed that Δψ m in resting, intact ND5 mutant cybrids was significantly lower than in matching control cybrids (72%, p<0.05) [9] . In permeabilized cells, the TMRM intensity in ND5 mutant mitochondria was only 31.3% (p<0.05) of control cybrid mitochondria at a [Ca 2+ ] of 62 nM (Fig 3B) . This further decrease in ND5 mutant Δψ m is likely a result of the diminished ATP pool after permeabilization, as glycolytically derived ATP is required (in part) to maintain Δψ m in ND5 mutant mitochondria [9] . (Fig 4B) , however the addition of FCCP still elicited a small depolarization (Fig 4B) . Of note, Δψ m in ND5 mutant mitochondria was higher than in ρ 0 mitochondria after permeabilization, suggesting that the reduced respiratory activity in ND5 mutant mitochondria can maintain a modest Δψ m in the absence of glycolytically derived ATP (Fig 4B) (Fig 4C) . ] c was measured using the ratiometric dye fura-2 AM on an epifluorescence imaging system. Thapsigargin was used to block the Ca 2+ -ATPase to release endoplasmic reticulum (ER) calcium stores, followed by the addition of ionomycin to release mitochondrial calcium. Calcium release from ER stores was not different between control (CON) cybrids and ND5 mutant cybrids, but was significantly reduced in ρ 0 cells. However, calcium release from mitochondrial stores was significantly lower in ND5 mutant cybrids lower (66.4 ± 15.8%) that CON cybrids. Stored mitochondrial calcium was also significantly lower in ρ 0 cells compared to CON cybrids (21.3 ± 11.7%). Data is mean ± s.d. n = 3.*p<0.05. Calcium buffering in ND5 mutant cybrids is dependent on ATP derived from glycolysis
We have previously shown that ND5 mutant cybrids primarily use glycolysis to generate ATP, and that this ATP is utilized to partially maintain Δψ m [9] . Here, we examined the effects of inhibiting glycolysis using 5mM 2-deoxy-D-glucose (2DG) on [Ca 2+ ] c .
In control (CON) cybrids, [Ca 2+ ] c remained unchanged up to 35 min after 2DG administration (Fig 5) . However, in ND5 mutant cybrids, [Ca 2+ ] c began to increase after approximately 10 min of 2DG treatment and remained significantly higher in ND5 than in control (CON) cybrids up to 35 min of treatment (Fig 5, p<0.05 ). In contrast, [Ca 2+ ] c increased significantly in ρ 0 cells after only 5 min 2DG treatment (p<0.05), followed by a slight reduction for the remainder of the experiment (Fig 5) .
Discussion
The relationship between mitochondrial metabolism and calcium signaling was first recognized in the early 1960's, when it was discovered that isolated mitochondria could take up calcium [14] . Since that time, it has become apparent that mitochondrial calcium handling is important in a range of different cellular functions, including neuronal signaling and induction of cell death [15] . Furthermore, it is now clear that defects in mitochondrial metabolism can disrupt cellular calcium homeostasis and contribute to human disease pathology. Various pathogenic mtDNA point mutations associated with mitochondrial disease have been shown to affect mitochondrial calcium handling. In fibroblasts from patients with MELAS, Δψ m was found to be reduced, with an associated increase in basal cytosolic Ca 2+ [7] . Similarly, cybrid ] c also increased significantly in ND5 mutant cybrids after approximately 12 min treatment, however this increase in [Ca cells carrying the m.3243A>G mutation associated with MELAS were also found to exhibit increased cytosolic calcium levels [16] . Mitochondrial calcium homeostasis is also altered in cybrids carrying the m.8344A>G tRNA Lys mutation associated with myoclonic epilepsy with ragged-red fibers (MERRF) and have been shown to have a decreased capacity to take up cytosolic calcium [8, 17] . In ND5 mutant cybrid mitochondria, we observed a decrease in both the mitochondrial calcium content and their ability take up increases in exogenous calcium. The homoplasmic m.13565C>T mtDNA mutation in these cybrids causes a respiratory defect that results in a reduced Δψ m , which is maintained in-part by glycolytically-derived ATP which fuels the reverse action of the ATP synthase [9] . Blocking glycolysis reduces Δψ m in ND5 mutant mitochondria further, with a subsequent elevation of cytosolic calcium levels. These findings support the notion that efficient mitochondrial metabolism is not only important for generating ATP, but that it is also critical for regulating cellular calcium homeostasis. Indeed, the calcium handling defect in ND5 mutant cybrid mitochondria appears to be directly related to their reduced Δψ m and their reliance on glycolytically derived ATP. However, their inability to accumulate calcium may also be due to defective calcium influx mechanisms. The inherent respiratory defect in these cells will result in a diminished electrogenic force across the mitochondrial inner membrane, which in turn may reduce calcium influx via the mitochondrial calcium uniporter [18] .
When [Ca 2+ ] reached 2.48 μM in control cybrids, a large depolarization of Δψ m was observed, indicating the initiation of mitochondrial membrane permeability transition. Interestingly, a large membrane depolarization was not observed in either the ND5 mutant cybrids or ρ 0 cells. This may be due to the fact that resting Δψ m in both these cell types is lower than Δψ m in control cybrids following membrane permeability transition. Nevertheless, it is possible that mitochondrial permeability transition, or low conductance pore opening, is occurring in both ND5 mutant cybrids and ρ 0 cells at high [Ca 2+ ].
Calcium is particularly important in neuronal cells, where calcium signaling is critical for signal processing. In these cells, defects in mitochondrial metabolism will have severe functional consequences, as the reduction in ATP generation will lead to elevated cytoplasmic calcium levels that disturb cell signaling pathways, confound normal signal processing, and may even promote cell death via calcium overload and/or excitotoxicity [19] . In neurons differentiated from mouse embryonic stem cells, which carry mtDNA mutations that disrupt OXPHOS complex I or IV activity, stimulation with glutamate resulted in calcium transients that were no different to control cybrid neurons [20] . However, repeated stimulation in the mutant neurons resulted in calcium transients that decayed increasingly slowly, resulting in elevated cytoplasmic calcium levels [20] . This loss of calcium regulation has the potential to disrupt neuronal transmitter release, long-term potentiation and depression, as well as developmental remodeling [20] .
It has long been postulated that disruption of cell death signaling pathways may be a contributing factor to mtDNA disease pathogenesis [21] . Furthermore, calcium homeostasis may play an important role in this process. Cybrid cells carrying the m.8344A>G mtDNA mutation associated with MERFF were shown to be hypersensitive to staurosporine-induced cell death, and that this hypersensitivity was mediated by the calcium-dependent activation of calpains [22] . Cybrids carrying the m.8993T>G NARP mutation also display increased sensitivity to cell death induction, in this case by thapsigargin [17] . However, MERRF cybrids are protected from thapsigargin-induced cell death, even though both the NARP and MERFF mutant cybrids display similar defects in mitochondrial calcium uptake [17] . This suggests that other factors are involved in regulating the response of these two mutant cybrids to ER stress. Indeed, NARP mutant cybrids showed a significant increase in free radical generation [17] and also disturbed actin cytoskeleton organization, which subsequently disrupts capacitative calcium entry [23] .
The ND5 mutant cybrids showed a reduced ability to generate ATP and exhibit defects in mitochondrial calcium accumulation, two features which serve to compound mitochondrial disease pathology. Of note, the m.13565C>T MT-ND5 mutation studied here was originally isolated from a MELAS patient who also carries a mutation in POLG, which encodes the catalytic subunit of the mitochondrial DNA polymerase [24] . Nevertheless, our transmitochondrial cybrid studies clearly show that the MT-ND5 mutation disrupts both mitochondrial respiratory function and calcium handling, and suggests that the MT-ND5 mutation may play a role in modulating the disease phenotype in conjunction with the POLG mutation.
Changes in cytosolic calcium concentration signal the mitochondria to match energy supply with demand, in particular by regulating mitochondrial dehydrogenase activity [25] [26] [27] [28] . However, failure of mitochondria to accumulate calcium, as in ND5 mutant cybrids, will result in the loss of TCA cycle enzyme stimulation, a lower than required respiratory rate and subsequently a reduced Δψ m . This will have a profound impact on cell metabolism, with energetic failure or collapse of Δψ m leading to cell death [6] . As such, mitochondrial calcium handling is an important factor to consider when investigating mitochondrial disease pathogenesis. Furthermore, the future design of therapies for treating mitochondrial disease will need to address not only the energetic deficits caused by OXPHOS dysfunction but also the means to re-establish mitochondrial calcium homeostasis.
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